Solid Biosciences SLDB
-
-
-
已收盤:-
本益比明細
年季 | 收盤價 | 本業佔比% | 本益比(近四季) | 每股稅後盈餘(元) | 營業利益(千) | 稅後純益(百萬) |
---|---|---|---|---|---|---|
2024Q4 | 4.00 | 93.82 | -1.02 | -39,896 | -43 | |
2024Q3 | 6.97 | 107.78 | -0.79 | -35,182 | -33 | |
2024Q2 | 5.67 | 111.22 | -0.61 | -27,788 | -25 | |
2024Q1 | 13.32 | 110.96 | -0.64 | -26,862 | -24 | |
2023Q4 | 6.14 | 107.69 | -1.00 | -22,265 | -20 | |
2023Q3 | 2.52 | 108.96 | -1.04 | -23,114 | -21 | |
2023Q2 | 5.24 | 108.46 | -1.25 | -26,843 | -25 | |
2023Q1 | 4.74 | 106.52 | -1.54 | -32,030 | -30 | |
2022Q4 | 5.38 | 228.14 | -0.68 | -34,566 | -15 | |
2022Q3 | 7.00 | 103.54 | -2.71 | -21,132 | -20 | |
2022Q2 | 9.23 | 101.16 | -3.34 | -25,382 | -25 | |
2022Q1 | 18.00 | 100.17 | -3.37 | -25,372 | -25 | |
2021Q4 | 26.25 | 100.23 | -2.52 | -18,652 | -19 | |
2021Q3 | 35.85 | 100.27 | -2.43 | -18,031 | -18 | |
2021Q2 | 54.90 | 100.09 | -2.40 | -18,685 | -19 | |
2021Q1 | 82.95 | -2.85 | -16,886 | -17 | ||
2020Q4 | 113.70 | 99.93 | -4.65 | -21,347 | -21 | |
2020Q3 | 30.45 | -6.60 | -21,226 | -21 | ||
2020Q2 | 43.95 | -5.85 | -18,974 | -19 | ||
2020Q1 | 35.85 | 100.62 | -8.40 | -26,859 | -27 |